224 related articles for article (PubMed ID: 17501851)
1. Mmp-9 immunoreactivity in acute migraine.
Leira R; Sobrino T; Rodríguez-Yáñez M; Blanco M; Arias S; Castillo J
Headache; 2007 May; 47(5):698-702. PubMed ID: 17501851
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma matrix metalloproteinase-9 levels in migraineurs.
Imamura K; Takeshima T; Fusayasu E; Nakashima K
Headache; 2008 Jan; 48(1):135-9. PubMed ID: 18005141
[TBL] [Abstract][Full Text] [Related]
3. Different circulating metalloproteinases profiles in women with migraine with and without aura.
Martins-Oliveira A; Speciali JG; Dach F; Marcaccini AM; Gonçalves FM; Gerlach RF; Tanus-Santos JE
Clin Chim Acta; 2009 Oct; 408(1-2):60-4. PubMed ID: 19627981
[TBL] [Abstract][Full Text] [Related]
4. Serum S100beta protein in children with acute recurrent headache: a potentially useful marker for migraine.
Papandreou O; Soldatou A; Tsitsika A; Kariyannis C; Papandreou T; Zachariadi A; Papassotiriou I; Chrousos GP
Headache; 2005; 45(10):1313-6. PubMed ID: 16324163
[TBL] [Abstract][Full Text] [Related]
5. Platelet levels of dopamine are increased in migraine and cluster headache.
D'Andrea G; Granella F; Perini F; Farruggio A; Leone M; Bussone G
Headache; 2006 Apr; 46(4):585-91. PubMed ID: 16643552
[TBL] [Abstract][Full Text] [Related]
6. Impact of migraine attacks on the blood-brain barrier.
Gao HM; Li L; Zhang KL; Chen XH; Tian SQ; Zhang ZL
Chin Med J (Engl); 2010 Sep; 123(18):2559-61. PubMed ID: 21034616
[TBL] [Abstract][Full Text] [Related]
7. New implications of the proteolytic balance between matrix metalloproteinases and their tissue inhibitors in migraine with and without aura.
Mannello F
Clin Chim Acta; 2009 Nov; 409(1-2):1-3. PubMed ID: 19632213
[TBL] [Abstract][Full Text] [Related]
8. Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine.
Martins-Oliveira A; Gonçalves FM; Speciali JG; Fontana V; Izidoro-Toledo TC; Belo VA; Dach F; Tanus-Santos JE
J Neuroimmunol; 2012 Nov; 252(1-2):89-94. PubMed ID: 22907074
[TBL] [Abstract][Full Text] [Related]
9. Systemic expression of matrix metalloproteinase-9 in patients with cerebral arteriovenous malformations.
Starke RM; Komotar RJ; Hwang BY; Hahn DK; Otten ML; Hickman ZL; Garrett MC; Sisti MB; Lavine SD; Meyers PM; Solomon RA; Connolly ES
Neurosurgery; 2010 Feb; 66(2):343-8; discussion 348. PubMed ID: 20087134
[TBL] [Abstract][Full Text] [Related]
10. Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome.
Gómez-Hernández A; Sánchez-Galán E; Ortego M; Martín-Ventura JL; Blanco-Colio LM; Tarín-Vicente N; Jiménez-Nacher JJ; López-Bescos L; Egido J; Tuñón J
Am J Cardiol; 2008 Jul; 102(1):12-8. PubMed ID: 18572029
[TBL] [Abstract][Full Text] [Related]
11. Implications of clinical subtypes of migraine with aura.
Eriksen MK; Thomsen LL; Olesen J
Headache; 2006 Feb; 46(2):286-97. PubMed ID: 16492238
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
[TBL] [Abstract][Full Text] [Related]
13. CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine.
Gupta VK
Expert Rev Neurother; 2009 Nov; 9(11):1595-614. PubMed ID: 19903020
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases during and outside of migraine attacks without aura.
Ashina M; Tvedskov JF; Lipka K; Bilello J; Penkowa M; Olesen J
Cephalalgia; 2010 Mar; 30(3):303-10. PubMed ID: 19614693
[TBL] [Abstract][Full Text] [Related]
15. Endothelial progenitor cells: a new key for endothelial dysfunction in migraine.
Rodríguez-Osorio X; Sobrino T; Brea D; Martínez F; Castillo J; Leira R
Neurology; 2012 Jul; 79(5):474-9. PubMed ID: 22815557
[TBL] [Abstract][Full Text] [Related]
16. [Expression of matrix metalloproteinase MMP-9 in the plasma and hematoma fluid of intracerebral hemorrhage patients].
Wu CH; Huang FY; Wang KY; Huang SY; Yang RL; Li HZ; Lei HX; Lin JS; Wang JM; Yan XH
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):174-6. PubMed ID: 18361815
[TBL] [Abstract][Full Text] [Related]
17. MMP and TIMP alterations in asymptomatic and symptomatic severe recurrent carotid artery stenosis.
Sapienza P; Borrelli V; di Marzo L; Cavallaro A
Eur J Vasc Endovasc Surg; 2009 May; 37(5):525-30. PubMed ID: 19297218
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of matrix metalloproteinase-9 in Henoch-Schönlein purpura.
Zou CC; Zhao ZY; Tang LF; Liang L
Scand J Rheumatol; 2006; 35(1):52-5. PubMed ID: 16467043
[TBL] [Abstract][Full Text] [Related]
19. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
Yildiz B; Kural N; Colak O; Ak I; Akcar N
Clin Physiol Funct Imaging; 2008 Mar; 28(2):107-12. PubMed ID: 18093232
[TBL] [Abstract][Full Text] [Related]
20. Acute and interictal allodynia in patients with different headache forms: an Italian pilot study.
Lovati C; D'Amico D; Bertora P; Rosa S; Suardelli M; Mailland E; Mariani C; Bussone G
Headache; 2008 Feb; 48(2):272-7. PubMed ID: 18081821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
